Pinpointing the prevalence of mismatch repair (MMR)-deficient rectal adenocarcinomas

byBrigham and Women's HospitalCredit: Pixabay/CC0 Public DomainA widely-circulated clinical trial published earlier this year in theNew England Journal of Medicine (NEJM)describe

Updated on: December 26,2023

Pinpointing the prevalence of mismatch repair (MMR)-deficient rectal adenocarcinomas

byBrigham and Women's HospitalCredit: Pixabay/CC0 Public DomainA widely-circulated clinical trial published earlier this year in theNew England Journal of Medicine (NEJM)describe

Updated on:December 26,2023

Cardio or weights first? A kinesiologist explains how to optimize the order of your exercise routine

by Randal Claytor,The ConversationCredit: CC0 Public DomainWhen you enter the gym, which way should you head first? Toward the treadmills and spin studio to get your sweat on with a cardio sessi

Updated on: May 16,2024

Cardio or weights first? A kinesiologist explains how to optimize the order of your exercise routine

by Randal Claytor,The ConversationCredit: CC0 Public DomainWhen you enter the gym, which way should you head first? Toward the treadmills and spin studio to get your sweat on with a cardio sessi

Updated on:May 16,2024

Flu virus variants resistant to new antiviral drug candidate lose pathogenicity, study finds

by LaTina Emerson,Georgia State UniversityCredit: Pixabay/CC0 Public DomainInfluenza A viruses with induced resistance to a new candidate antiviral drug were found to be impaired in cell culture

Updated on: May 06,2024

Flu virus variants resistant to new antiviral drug candidate lose pathogenicity, study finds

by LaTina Emerson,Georgia State UniversityCredit: Pixabay/CC0 Public DomainInfluenza A viruses with induced resistance to a new candidate antiviral drug were found to be impaired in cell culture

Updated on:May 06,2024

Immunotherapy improves survival in metastatic or recurrent head and neck cancer

byEuropean Society for Medical OncologyProf Barbara Burtness, Yale School of Medicine and Co-Director, Development Therapeutics Research Program, Yale Cancer Center, New Haven, US, study author.

Updated on: December 18,2023

Immunotherapy improves survival in metastatic or recurrent head and neck cancer

byEuropean Society for Medical OncologyProf Barbara Burtness, Yale School of Medicine and Co-Director, Development Therapeutics Research Program, Yale Cancer Center, New Haven, US, study author.

Updated on:December 18,2023

Researchers find the key to genome-modifying drugs' sensitivity in malignant blood diseases

by Josep Carreras Leukaemia Research InstituteImpact of azacitidine on global DNA methylation patterns and definition of EPIAZA signature in patients with MDS. (A) Study design and workflow. (B,

Updated on: March 20,2024

Researchers find the key to genome-modifying drugs' sensitivity in malignant blood diseases

by Josep Carreras Leukaemia Research InstituteImpact of azacitidine on global DNA methylation patterns and definition of EPIAZA signature in patients with MDS. (A) Study design and workflow. (B,

Updated on:March 20,2024

Developing AI tools for breast cancer precision pathology

byKarolinska InstitutetCredit: Pixabay/CC0 Public DomainBreast cancer is the most common cancer type in women globally, but there is a continuous decline in mortality rates. A partial explanatio

Updated on: December 26,2023

Developing AI tools for breast cancer precision pathology

byKarolinska InstitutetCredit: Pixabay/CC0 Public DomainBreast cancer is the most common cancer type in women globally, but there is a continuous decline in mortality rates. A partial explanatio

Updated on:December 26,2023

Scientists reveal how different cancer cells 'team up' to help incurable childhood brain tumor spread

byInstitute of Cancer ResearchSimulating cellular invasion (A) Illustration of simulation flow. (B) Summary statistics used to measure invasion: (i)traveling-wave solution to reaction-diff

Updated on: December 27,2023

Scientists reveal how different cancer cells 'team up' to help incurable childhood brain tumor spread

byInstitute of Cancer ResearchSimulating cellular invasion (A) Illustration of simulation flow. (B) Summary statistics used to measure invasion: (i)traveling-wave solution to reaction-diff

Updated on:December 27,2023

Differences in animal biology can affect cancer drug development

byWeill Cornell Medical CollegeDifferential co-occurrence and effects of KRAS, TP53 and LKB1 mutations on human and mouse LUADs (A) MSK Impact oncoprint of co-occurrence of KRAS, TP53 and LKB1 m

Updated on: December 20,2023

Differences in animal biology can affect cancer drug development

byWeill Cornell Medical CollegeDifferential co-occurrence and effects of KRAS, TP53 and LKB1 mutations on human and mouse LUADs (A) MSK Impact oncoprint of co-occurrence of KRAS, TP53 and LKB1 m

Updated on:December 20,2023

Scientists are one step closer to stopping drug-resistant tumors from growing

by Heather Simonsen, Huntsman Cancer InstituteBenjamin Myers, PhD in lab. Credit: Huntsman Cancer InstituteScientists have solved a long-standing mystery surrounding a cancer-promoting protein and how

Updated on: December 27,2023

Scientists are one step closer to stopping drug-resistant tumors from growing

by Heather Simonsen, Huntsman Cancer InstituteBenjamin Myers, PhD in lab. Credit: Huntsman Cancer InstituteScientists have solved a long-standing mystery surrounding a cancer-promoting protein and how

Updated on:December 27,2023

Financial impacts of cancer found to intensify disease burden among German patients

byEuropean Society for Medical OncologyA study conducted in Germany draws attention to the fact that the socio-economic burden of cancer is real in Europe too, and not only in the context of the

Updated on: December 18,2023

Financial impacts of cancer found to intensify disease burden among German patients

byEuropean Society for Medical OncologyA study conducted in Germany draws attention to the fact that the socio-economic burden of cancer is real in Europe too, and not only in the context of the

Updated on:December 18,2023

Three-drug combination therapy effective in patients with high-risk chronic lymphocytic leukemia, trial shows

byDana-Farber Cancer InstituteNew research shows that genetics account for only five to 10 per cent of risk for most human diseases, and that gene testing is a poor predictor of whether someone

Updated on: January 04,2024

Three-drug combination therapy effective in patients with high-risk chronic lymphocytic leukemia, trial shows

byDana-Farber Cancer InstituteNew research shows that genetics account for only five to 10 per cent of risk for most human diseases, and that gene testing is a poor predictor of whether someone

Updated on:January 04,2024

Third-generation anti-CD19 CAR T-cells show efficacy without neurotoxicity in B-cell lymphoma phase 1 clinical trial

byMalaghan Institute of Medical ResearchMalaghan Institute GMP lab where CAR T-cells were manufactured for the phase 1 trial. Credit: Malaghan Institute of Medical ResearchThe Malaghan Institute

Updated on: January 26,2024

Third-generation anti-CD19 CAR T-cells show efficacy without neurotoxicity in B-cell lymphoma phase 1 clinical trial

byMalaghan Institute of Medical ResearchMalaghan Institute GMP lab where CAR T-cells were manufactured for the phase 1 trial. Credit: Malaghan Institute of Medical ResearchThe Malaghan Institute

Updated on:January 26,2024